FDA Approves Merck’s ENFLONSIA for RSV Prevention in Infants
Merck, known as MSD outside of the United States and Canada, announced the U.S. Food and Drug Administration (FDA) has approved ENFLONSIA™ (clesrovimab-cfor) for the prevention of…
Read More...
Read More...
